➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: February 25, 2021

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Children's Advil-flavored patents expire, and what generic alternatives are available?

Children's Advil-flavored is a drug marketed by Glaxosmithkline and is included in one NDA. There is one patent protecting this drug.

This drug has nine patent family members in eight countries.

The generic ingredient in CHILDREN'S ADVIL-FLAVORED is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and eight suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

US ANDA Litigation and Generic Entry Outlook for Children's Advil-flavored

A generic version of CHILDREN'S ADVIL-FLAVORED was approved as ibuprofen by OHM on July 15th, 1986.

  Start Trial

Drug patent expirations by year for CHILDREN'S ADVIL-FLAVORED
Recent Clinical Trials for CHILDREN'S ADVIL-FLAVORED

Identify potential brand extensions & 505(b)(2) entrants

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Phase 1
University of MinnesotaPhase 3
National Institute for Health Research, United KingdomN/A

See all CHILDREN'S ADVIL-FLAVORED clinical trials

US Patents and Regulatory Information for CHILDREN'S ADVIL-FLAVORED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline CHILDREN'S ADVIL-FLAVORED ibuprofen SUSPENSION;ORAL 020589-002 Nov 7, 1997 OTC No No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.